Company Filing History:
Years Active: 2010
Title: Bjarne Brudeli: Innovator in Peripheral 5-HT Receptor Modulation
Introduction
Bjarne Brudeli is a notable inventor based in Oslo, Norway. He has made significant contributions to the field of pharmacology, particularly in the modulation of peripheral 5-HT receptors. His work has implications for treating various medical conditions without the side effects commonly associated with central nervous system activity.
Latest Patents
Bjarne Brudeli holds a patent for "Modulators of peripheral 5-HT receptors." This invention focuses on modulators that are selectively targeted at peripheral 5-HT receptors, especially the 5-HT4 receptors. The invention is particularly relevant for treating gastrointestinal disorders, lower urinary tract disorders, and cardiovascular disorders, providing therapeutic options that minimize central nervous system side effects.
Career Highlights
Throughout his career, Bjarne has worked with several companies, including Serodus AS and Golden Omega Norway AS. His experience in these organizations has allowed him to apply his innovative ideas in practical settings, contributing to advancements in medical treatments.
Collaborations
Bjarne Brudeli has collaborated with notable individuals in his field, including Jo Klaveness and Finn Olav Levy. These partnerships have likely enriched his research and development efforts, fostering a collaborative environment for innovation.
Conclusion
Bjarne Brudeli's work in the modulation of peripheral 5-HT receptors represents a significant advancement in medical science. His innovative approach has the potential to improve treatment options for various disorders while minimizing side effects.